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Abstract
Background: The accuracy of quantitative real-time PCR (qRT-PCR) is highly dependent on reliable reference gene(s). Some
housekeeping genes which are commonly used for normalization are widely recognized as inappropriate in many
experimental conditions. This study aimed to identify reference genes for clinical studies through microarray meta-analysis
of human clinical samples.
Methodology/Principal Findings: After uniform data preprocessing and data quality control, 4,804 Affymetrix HU-133A
arrays performed by clinical samples were classified into four physiological states with 13 organ/tissue types. We identified a
list of reference genes for each organ/tissue types which exhibited stable expression across physiological states.
Furthermore, 102 genes identified as reference gene candidates in multiple organ/tissue types were selected for further
analysis. These genes have been frequently identified as housekeeping genes in previous studies, and approximately 71% of
them fall into Gene Expression (GO:0010467) category in Gene Ontology.
Conclusions/Significance: Based on microarray meta-analysis of human clinical sample arrays, we identified sets of
reference gene candidates for various organ/tissue types and then examined the functions of these genes. Additionally, we
found that many of the reference genes are functionally related to transcription, RNA processing and translation. According
to our results, researchers could select single or multiple reference gene(s) for normalization of qRT-PCR in clinical studies.
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Introduction
Reference genes (RGs) are widely used to normalize the
expression level for removing potential artifacts caused by sample
preparation and detection as well as to provide an accurate
comparison of gene expression among different samples. Tradi-
tional reference genes (tRGs) are housekeeping genes (HKGs),
such as ACTB, GAPDH, and HPRT, and usually serve as internal
controls in Northern blot, RNase protection assays, conventional
RT-PCR assays, and quantitative real-time PCR (qRT-PCR). The
assumption is that these genes are defined as maintaining basic
cellular functions [1] and are expressed at a constant level across
samples, physiological states, and treatments. However, numerous
studies have already shown that tRGs are regulated and their
expression levels are varied under certain experimental conditions
[2,3,4,5].
qRT-PCR is often considered as the golden standard for
quantitative gene expression analysis. However, the use of
inappropriate RGs can result in incorrect findings if the expression
levels of the chosen RGs are influenced by the experimental
conditions [3,6]. Researchers should make sure that the chosen
RGs are suitable for the experiment they conducted. Thus,
identification of RGs and their validation within specific biological
conditions under investigation are critical issues.
Previous research identified RGs by selecting them from a list of
tRGs for specified biological conditions according to the results of
qRT-PCR [7,8,9,10,11,12]. Microarray screening is an alternative
approach and has the potential to identify novel RGs whose
expression levels are more stable than that of tRGs. Moreover, the
increasing amount of microarray data is an excellent source for the
identificationofgeneswiththe most stableexpression [13,14,15,16].
Most research using microarray analysis identified RGs for specific
biological conditions, for example, evolution [17], differentiation
[18], development [19], treatment [20], cancer [13,14,21,22,
23,24,25,26], other diseases [27,28,29,30] or comparing different
physiological stages of a single organ [21,23,25]. A number of
studies have identified RGs with relatively stable expressions across
tissue types [31] and among metadata which pooled multitudes of
arrays ignoring cell types and experimental conditions [32,33].
However, no results have been reached for a consistent set of RGs.
Many researchers assume that no RG is universally stable in its
expression in all situations [14,22,23,28,34]. The ideal set of RGs
depends on the biological conditions and should be selected and
evaluated for each series of experiments.
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analysis of human clinical samples. These RGs had to demonstrate
a stable expression across various physiological states in individual
tissue/organ type. After the removal of poor quality arrays, 4,804
Affymetrix U133A arrays performed on human clinical samples
were selected from the M
2DB, a microarray meta-analysis
database [35]. These arrays were classified into 4 physiological
states and 13 organ/tissue types. Genes showing stable expressions
within and between physiological stages for a single tissue were
identified as RGs for that particular tissue. Our results
recommended a number of sets of RGs for various organ/tissue
types. Additionally, we have found that the genes that are
frequently identified as RGs for multiple organ/tissue types are
highly related to the functional category, Gene Expression (GO:
0010467). These genes are frequently classified as HKGs in
previous studies. Besides, our results suggest that RGs identified in
this study are candidates as control genes for qRT-PCR in clinical
studies.
Analysis
Microarray data collection, quality control, and
pre-processing
Expression data were collected from the M
2DB, which compiles
more than 10,000 well-annotated, published, human clinical
Affymetrix GeneChip arrays. We excluded poor quality arrays
(8% of the total), that did not match the criteria of the 95
percentile of PMVO [36], according to the QC metrics of the
M
2DB. Then, according to the annotation of the M
2DB, samples
related to the same organ/tissue type and the same physiological
state were classified into a single group. An organ/tissue type was
included into this study if it has at least two groups, which
contained at least 10 HG-U133A arrays, in the organ/tissue type.
In summary, this study included 4,804 HG-U133A arrays
classified into 13 organ/tissue types and 4 physiological states
(Normal, Abnormality, Disease, and Cancer or Tumor). Table 1
gives the summary of the number of arrays classified in each
organ/tissue and physiological state. The data uniformly processed
by the GC Robust Multi-array Average (GCRMA) algorithm [37]
were downloaded from the M
2DB. Intensities (without log
transformation) of the probe sets with the same Entrez GeneID
were averaged to represent the expression of the corresponding
gene.
Selection of Reference Gene Candidates
The definition of an RG in this study is that a gene stably
expressed for each organ across different physiological states. RGs
for each organ/tissue type were identified using the following
criteria:
1. Iiw100 and FP.80%.
2.
si
Ii
v0:3
3. Max(Ii=Ij)v1:2
Where Ii and Ij denote the mean intensity of the gene in arrays of
ith and jth physiological states respectively. si is the standard
deviation of intensity in ith physiological states. Max() is the
maximum ratio of mean intensity. For a gene, FP is fraction
Present which is the fraction of arrays called present in a single
organ/tissue type [38]. The first criterion identified genes that are
truly expressed in a tissue. For each gene, the expression values
were averaged for each physiological state. A gene was retained if
the average expression level exceeded the selected threshold value
100 and FP was larger than 80%. Filtering data by FP increases
the correlation between Affymetrix GeneChip and qRT-PCR
expression measurements [39]. Genes with their expression values
satisfy these two thresholds are most likely to be truly expressed.
The second criterion used the coefficient of variation, standard
deviation divided by mean intensity, to verify whether the genes
exhibited stable expressions in a physiological state. The third
criterion used fold change of expression to filter out genes that
differentially expressed across physiological states in a single
organ/tissue type. The fold change refers to the ratio of mean
intensity of physiological states and represents the expression
differences between physiological states. Table 2 shows the
number of genes which are stably expressed within individual
physiological state (the first and second criteria), stably expressed
Table 1. Summary of arrays classified into 4 physiological states and 13 organ/tissue types.
Organ/Tissue Types Physiological States
Normal Cancer or Tumor Disease Abnormality Total
blood 252 403 514 137 1,306
lung 44 92 66 128 330
bone marrow 39 559 19 0 617
brain 229 139 202 0 570
uterus 18 15 13 0 46
breast 10 1,229 0 3 1,242
kidney 9 21 0 10 40
bladder 12 64 0 0 76
lymph node 12 33 0 0 45
prostate 15 59 0 0 74
testis 17 102 0 0 119
muscle 75 0 109 44 228
heart 30 0 81 0 111
Total 762 2,716 1,004 322 4,804
doi:10.1371/journal.pone.0017347.t001
Selection of Reference Genes through Meta-Analysis
PLoS ONE | www.plosone.org 2 February 2011 | Volume 6 | Issue 2 | e17347across physiological states (the first and third criteria), and
qualified as RGs (all three criteria) for each organ/tissue type.
For example, by apply the first two criteria, the counts of genes
stably expressed within the four physiological states in blood are
133, 203, 479, and 238, respectively. By applying the first and
third criteria, there were 162 genes stably expressed across
physiological states in blood. Finally, 11 genes passed all three
criteria were identified as RGs for blood. Data S1 gives the
complete lists of RGs for respective organ/tissue types.
Frequent Reference Genes
The genes which were identified as RGs for at least three
organ/tissue types are denoted as frequent reference genes
(fRGs). Table 3 displays a list of 102 fRGs and the corresponding
numbers of organ/tissue types for which the RGs were identified.
Some tRGs, such as ACTB, B2M, UBC, RPL13A and RPLP0,
are also on this list. Gene ontology was used to analyze the gene
function of fRGs. A set of GO terms (14 terms) was chosen to give
a broad overview of gene function. Figure S1 generated by
QuickGO [40] is a graphical view of the term lineage of these 14
terms in Gene Ontology. Figure 1 shows the percentage of fRGs
counts in these 14 terms. Approximately 61%, 15%, and 7% of
fRGs belong to Translation (GO: 0006412), RNA Processing
(GO: 0006396), and Transcription (GO: 0006350) respectively.
Moreover, these three terms are children of Gene Expression
(GO: 0010467) (Figure S1). Approximately 71% of the fRGs fall
into this functional category. These are basic cellular functions
referring to HKGs. When compared with 8 lists of HKGs
identified by microarray or EST analysis in 7 previous studies
[16,41,42,43,44,45,46], fRGs were frequently classified as HKGs
in these lists. Furthermore, the percentages of these HKGs lists
falling into Gene Expression (GO: 0010467) range from 22.4 to
35.1 (Table 4). These percentages are much lower than that of
fRGs. In addition, these 14 terms cover 84% of fRGs. The other
16% of fRGs do not belong to these 14 GO terms, and half of
these genes do not refer to any GO terms.
Expression profiles of tRGs and fRGs
Six tRGs and six fRGs were selected to examine the expression
profiles. The 6 housekeeping genes (ACTB, B2M, GAPDH,
PKG1, RPLP0, and PPIA) have been commonly used as reference
genes for qRT-PCR in numerous studies. In this study, the 6 fRGs
(HUWE1, TPT1, EEF1A1, LRRC40, RPS20, RPL37A, and
RPL41) are the most frequently identified RGs in various organ/
tissue types (Table 3). Three of the housekeeping genes, ACTB,
B2M, and RPLP0, are also identified as fRGs. Although the other
three housekeeping gene are not fRGs, they are still identified as
RGs for one or two organs/tissue types. Figure 2 depicts the
intensity profile of the 12 genes (6 tRGs and 6 fRGs) in various
physiological states of 13 organ/tissue types. The RGs exhibit
consistent expressions in the corresponding organ/tissue type. The
6 fRGs exhibit more stable expression than the 6 tRGs do both
within and between organ/tissue types.
Discussion
We examined the variability of gene expression within and
between various physiological states in 13 organ/tissue types. Lists
of RGs were identified for the corresponding organ/tissue types.
Clinical research usually focused on various physiological states for
a single organ/tissue type (such as cancer classification [47,48,49]).
The relative expression level of an ideal RG for clinical studies
should not be significantly influenced by physiological states.
Previous studies, which used microarray screening to identify RGs,
mostly focused on a specific physiological state in an organ/tissue
type. Some research identified universal RGs by pooling all of
microarray data from public repositories ignoring organ/tissue
types and physiological states [31,32,33]. Different from them, our
study broadly searched RGs in various physiological stages of 13
organ/tissue types. To achieve this goal, we classified samples into
four physiological states according to information found in the
M
2DB. Then, we applied several criteria to identify expressed
genes with consistent expression within and between physiological
Table 2. Summary of the number of genes passed different criteria in 13 organ/tissue types.
Organ/Tissue types Stable Within Physiological States
*
Stable Between
Physiological States1 RGs¥
Normal Cancer or Tumor Disease Abnormality
blood 133 203 479 238 162 11
lung 211 117 768 581 195 16
bone marrow 186 66 382 - 301 21
brain 184 60 491 - 657 15
uterus 761 1,454 1,548 - 1,271 276
breast 352 108 - 2,263 378 17
kidney 201 1,041 - 2,542 421 31
bladder 362 200 - - 1,385 89
lymph node 2,212 495 - - 1,030 150
prostate 734 106 - - 1,989 65
testis 238 173 - - 713 13
muscle 327 - 198 478 1,103 93
heart 742 - 794 - 2,406 250
*The criterion is that the CV of the intensity of the gene in the physiological state is smaller than 30%. CV, coefficient of variation, is equal to standard deviation divided
by mean.
1The criterion is that the maximum of the fold change of mean intensity between physiological states is smaller than 1.2.
¥The number of genes stably expressed within and between physiological states.
doi:10.1371/journal.pone.0017347.t002
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exhibited stable expression and results indicated that the tRGs are
not always the best choice for reference of qRT-PCR (Figure 2).
Although numbers of genes in our RG list had been reported as
RGs for some experimental conditions in previous studies, our
results specified which gene could be RG in particular organ/
tissue types. For example, ACTB, the most frequently used tRG, is
also in our fRGs list, but we suggested that ACTB can only be
Table 3. fRGs and the corresponding numbers of organ/tissue types for which fRGs were identified.
Num. of organ/
tissue types Gene Symbol
3 SEPT2, ATG4B, B2M, BTF3, DAZAP2, DDB1, DDX17, EIF4G2, ENSA, EWSR1, FNTA, HDAC3, HDLBP, HMGB1, HMGN2, HNRNPA1, MORF4L1, MTCH1,
PI4KB, PUM1, RPL10, RPL11, RPL17, RPL19, RPL22, RPL4, RPL5, RPS12, RPS15, RPS28, RPS3, RPS7, TBC1D9B, TCEB3
4 ACTB, CCDC72, EEF1G, EEF2, FTHP1, GDI1, GTF2F1, GTPBP6, RPL12, RPL24, RPL27A, RPL30, RPL37, RPL38, RPL39, RPL7, RPL7A, RPLP0, RPLP1,
RPS16, RPS2, RPS24, RPS25, RPS27A, RPS3A, RPS4X, RPSA, SKP1, SNRPB2, SRP14, USP34
5 ACTG1, EEF1D, EIF1, MYL12B, OAZ1, RPL13A, RPL15, RPL21, RPL27, RPL31, RPL32, RPS13, RPS14, RPS15A, TOX4, UBA52
6 PNN, RPL34, RPL9, RPS10, RPS11, RPS17, RPS18, RPS23, RPS27, RPS29, UBB, UBC
7 NACAP1, RPL23A
8 EEF1A1, LRRC40, RPS20
9 RPL41
10 RPL37A, TPT1
11 HUWE1
doi:10.1371/journal.pone.0017347.t003
Figure 1. Gene Ontology Functional analysis of fRGs. The percentage of fRGs counted in 14 GO terms which give a broad overview of gene
function. Gene expression is the parent term of transcription, translation, and RNA processing in Gene Ontology and contains 71% of fRGs.
doi:10.1371/journal.pone.0017347.g001
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organ/tissue types which we investigated. Furthermore, unlike
some previous studies, our results indicated that there is no
universal RG for all experimental conditions listed in our study. As
the result, it also shows that choosing randomly any HKGs for
normalization is risky and may lead to erroneous results.
With rapidly accumulating metadata, microarray meta-analysis
is becoming more important in microarray research. One major
concern is that as more datasets are included into analysis, the
more variance could contribute to the result. Ramasamy et al. had
suggested several key issues for microarray meta-analysis [50].
Using pre-processed data based on different algorithms will
introduce variations into meta-analysis and the resulting data are
unlikely to be directly comparable. As Ramasamy et al. point out,
even for studies conducted using the same microarray platform;
the raw data should be uniformly pre-processed and normalized
using the same algorithm to remove systematic biases for all tested
datasets. Several studies have suggested considering data quality
within the context of microarray meta-analysis [50,51,52]. Poor
quality data must be identified and eliminated during data
processing [50,53]. In this study, we adopted single platform for
analysis to avoid the variance of combining different platforms,
and then uniformly pre-processed all arrays to eliminate the
technical variance of data transformation and removed poor
quality arrays to alleviate laboratory-to-laboratory variance [35].
Moreover, we used the 12 tRGs and fRGs in Figure 2 to evaluate
the effect of QC (Figure S2). The CV of intensity for these genes
with QC was lower compared to those without QC. This result
suggests that including poor quality arrays could lead to increase
expression variation. The advantageous effect of excluding poor
quality data is apparent when processing muscle tissues. More
than 40% of muscle sample arrays were identified as poor quality
arrays (8% of total arrays are poor quality). This result shows that
expression variations of RGs are greatly reduced when poor
quality muscle arrays were excluded.
Most genes included in lists of fRGs were commonly referred to as
HKGs in previous studies (Table 4). To a certain extent, this result is
in line with the original concept of using HKGs as RGs for
normalization. However, contrary to commonly held assumptions,
no HKGs were consistently expressed across all tissues in our study.
Moreover, no genes maintained a stable expression level under all
conditions (various organ/tissue types and physiological states)
(Table 4). In fact, this observation has been mentioned in previous
studies [14,22,23,28,34] which presumed there is no universal RGs
for all experimental conditions. Furthermore, approximately 71% of
fRGs’ were related to the function of Gene Expression (including
Transcription, Translation, and RNA Processing). The percentage is
much higher than those of HKGs lists by previous studies (Table 4).
Consequently, fRGs are highly related to HKGs and maintained at
relatively stable level. This result indicates that the genes in the Gene
Expression (GO: 0010467) category are more likely to be stably
expressed across physiological states and organ/tissue types. This
may imply these genes play more important roles than general
HKGs. Besides, we found that half of the fRGs were ribosomal
protein genes. A meta-analysis study conducted by de Jonge et al.
revealed 15 reference genes with the most constant expression, and
13 out of 15 genes were ribosomal proteins [32]. In contrast, Thorrez
et al. demonstrated that ribosomal protein genes exhibited important
tissue-dependent variations in mRNA expression [54]. Thorrez’s
results were based on the study of 70 microarrays, representing 22
tissues. The authors cautioned against using ribosomal protein genes
as a reference [54]. Our study, which preserved more sample
conditions, resolves the contradictory conclusions by these two
studies. Our results depicts that some ribosomal protein genes
maintained relative stability of expression across organ/tissue types,
however, some ribosomal proteins exhibited significant tissue-
dependent expression (for example, RPLP0 in Figure 2). The RGs
identified in this study expressed stably across physiological states in a
single organ/tissue type. Thus, a number of ribosomal protein genes
tallied with the criterion could be identified as RGs. For example, in
this study, more than half of RGs for breast are ribosomal protein
genes,whichisconsistentwiththeresultsofameta-analysistoidentify
RGs for breast cancer [26]. However, if the experiment is conducted
by various organ/tissue types, it required further verification to use
ribosomal protein genes as reference.
UBB, UBC, and UBA52 in the list of fRGs are known as
functions related to protein ubiquitination, as well as numerous
essential cellular functions. They have been identified as RGs in
breast cancer [26]. UBC is a tRG and has also been identified as
an RG in colon cancer [14]. TPT1 was initially described as a
growth-related protein, and it was recently shown being involved
in calcium homeostasis [55]. This implies the expression stability
of TPT1 could influence the calcium stability in cells. It could be
the reason that TPT1 was identified as RG in previous studies
[14,29] and for 10 organ/tissue types in this study. RPL41 and
EEFA1 in the list of fRGs have also been recognized as RG for
liver [23] and myocardium [29] respectively. GAPDH, the most
common tRG, was identified as RG only for heart and muscle in
Table 4. Comparison of fRGs with HKG lists of previous studies.
References Tech. % of overlap
* % in Gene Expression (GO: 0010467)
1
Warrington et al. 2000 [16] Microarray 59.8 31.9
Hsiao et al. 2001 [46] Microarray 58.8 35.1
Eisenberg et al. 2003 [45] Microarray 43.1 27.2
Tu et al. 2006 [44] Microarray 75.5 22.4
Zhu et al. 2008 [42] EST 92.2 24.5
Zhu et al. 2008 [42] Microarray 85.3 26.1
Dezso et al. 2008 [43] Microarray 81.4 24.3
She et al. 2009 [41] Microarray 68.6 29.1
fRGs Microarray - 70.6.
*The percentage of fRGs falls into HKG lists.
1The percentage of genes in these lists falls into Gene Expression (GO: 0010467) category in Gene Ontology.
doi:10.1371/journal.pone.0017347.t004
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which identified GAPDH as a RG for myocardium [29].
HUWE1, which is related to histone ubiquitination [56] and
protein polyubiquitination [57], was the top-ranked RG in our
result. Although HUWE1 was not the most stable gene in
individual organ/tissue type, it was the gene most frequently
identified as RG in this study, and suggested to be a novel RG
candidate for clinical studies.
Geometric averaging of multiple RGs rather than using single
RG for normalization of qRT-PCR is an alternative strategy [58].
We have supplied lists of RG candidates for researchers to confirm
their qRT-PCR results under particular experimental conditions.
Choosing several RG candidates from our RG lists to perform
qRT-PCR could help researchers to confirm one or multiple RGs
for use as references.
For some organ/tissue types, there were only dozens of samples
for identifying RGs, despite the thousands of arrays included in
this study (Table 1). This might underestimate the variance of
expression among individuals or physiological conditions and
might lead to increased false positive rate. For example, 276 RG
candidates were identified for the uterus (Table 2). There is a
limitation of accuracy in identifying RG upon small number of
samples. However, our RG list can be good candidates for
researchers to identify the true RG by qRT-PCR but not choosing
Figure 2. Expression profiles of 6 tRGs and 6 fRGs for 4 physiological states in 13 organ/tissue types. The upper and lower halfs of the
figure are 6 fRGs and 6 tRGs respectively. The error bar is the standard deviation of intensity. * denotes the gene identified as RG in the organ/tissue
type.
doi:10.1371/journal.pone.0017347.g002
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RGs which had been shown variable expression in our results.
Using the same example, the most used tRG, GAPDH, is not
included in the 276 RG candidates for the uterus. Thus,
researchers could choose several candidate genes in our list for
further validation by qRT-PCR but GAPDH. In the future, with
rapidly accumulated microarray metadata, we could gather more
clinical arrays and subdivide them by detailed physiological states
and organ/tissue types. Accordingly, the more accurate RGs could
be identified for clinical studies.
In summary, this study performed microarray meta-analysis to
compile lists of RG candidate for 13 organ/tissue types. We
provided lists of RG candidates for researchers to select single or
multiple genes as references for the normalization of qRT-PCR in
clinical studies. We also found that fRGs were recognized as
HKGs in previously studies and about 71% of fRGs were
functional annotated to Gene Expression (GO:0010467). The
percentage is also much higher than that of HKG lists. To our best
knowledge, this is the first study considering different physiological
states as well as identifying RGs for various organ/tissue types. In
our results, the tRGs are not the best choice for reference of qRT-
PCR in most conditions, and the RGs identified in this study are
more reliable than tRGs for normalization in qRT-PCR for
clinical studies.
Supporting Information
Data S1 The complete lists of RGs for the 13 organ/tissue types.
For each gene, the CV and mean intensity of various physiological
states are also included in this file.
(XLS)
Figure S1 The lineage of 14 GO terms.
(TIF)
Figure S2 The CV of intensity of 12 genes in 13 organ/tissue
types with/without QC filitering.
(TIF)
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